Biocomputing drug repurposing toward targeted therapies

Aging

Volumn 8, Issue 11, 2016, Pages 2609-2610

  Cardone, Luca ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Drugs network; FDA approved drugs; Gene expression signatures; Oncogenes; PI3K dependent pathways

Indexed keywords

BIOLOGY; DRUG REPOSITIONING; HUMAN; MOLECULARLY TARGETED THERAPY; NEOPLASM; PROCEDURES;

COMPUTATIONAL BIOLOGY; DRUG REPOSITIONING; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 85002198099     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.101135     Document Type: Editorial

References (7)

1. Pagliarini R, et al. EMBO Rep. 2015; 16:280-96. doi:10.15252/embr.201439949.
2. Garraway LA and Jänne PA. Cancer Discov. 2012;2:214-26. doi: 10.1158/2159-8290.CD-12-0012.
3. O'Connor KA et al. Nat Rev Drug Discov. 2005; 4:1005-14. doi: 10.1038/nrd1900.
4. Carrella D, et al. Oncotarget. 2016; doi:10.18632/oncotarget.11318. Epub ahead of print.
5. Iorio F, et al. Proc Natl Acad Sci U S A. 2010;107:14621-26. doi: 10.1073/pnas.1000138107.
6. Bild AH, et al. Nature. 2006; 439:353-57. doi:10.1038/nature04296.
7. Nevins JR, et al. Nat Rev Genet. 2007; 8:601-09. doi:10.1038/nrg2137.